Cargando…

Muscle Loss after Chemoradiotherapy as a Biomarker of Distant Failures in Locally Advanced Cervical Cancer

This study aimed to evaluate whether computed tomography (CT)-based muscle measurement predicts distant failure in patients with locally advanced cervical cancer (LACC). Data from 278 patients with LACC who underwent chemoradiation therapy (CCRT) between 2004 and 2017 were analysed. Changes in the s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jie, Lin, Jhen-Bin, Wu, Meng-Hao, Chang, Chih-Long, Jan, Ya-Ting, Chen, Yu-Jen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139727/ https://www.ncbi.nlm.nih.gov/pubmed/32150938 http://dx.doi.org/10.3390/cancers12030595

Ejemplares similares

Muscle radiodensity loss during cancer therapy is predictive for poor survival in advanced endometrial cancer
por: Lee, Jie, et al.
Publicado: (2019)

Safety and efficacy of semiextended field intensity-modulated radiation therapy and concurrent cisplatin in locally advanced cervical cancer patients: An observational study of 10-year experience
por: Lee, Jie, et al.
Publicado: (2017)

Progressive Skeletal Muscle Loss After Surgery and Adjuvant Radiotherapy Impact Survival Outcomes in Patients With Early Stage Cervical Cancer
por: Lee, Jie, et al.
Publicado: (2022)

Predictive factors for early distant metastasis after neoadjuvant chemoradiotherapy in locally advanced rectal cancer
por: Park, Hyojung
Publicado: (2021)

MRI Using Artificial Intelligence Algorithm to Evaluate Concurrent Chemoradiotherapy for Local Recurrence and Distant Metastasis of Cervical Squamous Cell Carcinoma
por: Wu, Youyi, et al.
Publicado: (2022)

Endostar, an Antiangiogenesis Inhibitor, Combined With Chemoradiotherapy for Locally Advanced Cervical Cancer
por: Lu, Heming, et al.
Publicado: (2022)

Retracted: MRI Using Artificial Intelligence Algorithm to Evaluate Concurrent Chemoradiotherapy for Local Recurrence and Distant Metastasis of Cervical Squamous Cell Carcinoma
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Treatment results of incomplete chemoradiotherapy in locally advanced cervical cancer
por: Gao, Ying, et al.
Publicado: (2013)

Concurrent Chemoradiotherapy without Brachytherapy in Locally Advanced Cervical Cancer
por: Kadkhodayan, Sima, et al.
Publicado: (2013)

Impact of neoadjuvant chemoradiotherapy on the local recurrence and distant metastasis pattern of locally advanced rectal cancer: a propensity score-matched analysis
por: Yu, Liang, et al.
Publicado: (2021)

Safety and efficacy of nimotuzumab combined with chemoradiotherapy in Chinese patients with locally advanced cervical cancer
por: Chen, Yong-Fa, et al.
Publicado: (2017)

Extrafascial hysterectomy after concurrent chemoradiotherapy in locally advanced cervical adenocarcinoma
por: Yang, Jie, et al.
Publicado: (2016)

The Impact of Addition of Consolidation Chemotherapy to Standard Cisplatin-Based Chemoradiotherapy in Uterine Cervical Cancer: Matter of Distant Relapse
por: Fabri, Vanessa A., et al.
Publicado: (2019)

Neoadjuvant Chemoradiotherapy for Locally Advanced Gastric Cancer: Where Are We at?
por: Yeh, Jen-Hao, et al.
Publicado: (2022)

Deep learning radiomics-based prediction of distant metastasis in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy: A multicentre study
por: Liu, Xiangyu, et al.
Publicado: (2021)

Detecting Interval Distant Metastases With (18)F-FDG PET/CT After Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Cancer
por: Kroese, Tiuri E., et al.
Publicado: (2022)

Chemoradiotherapy alone vs. chemoradiotherapy and hysterectomy for locally advanced cervical cancer: A systematic review and updated meta-analysis
por: Lu, Weijia, et al.
Publicado: (2021)

Adjuvant hysterectomy in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy
por: Shim, Seung-Hyuk
Publicado: (2019)

Effectiveness of Concomitant Chemoradiotherapy with Gemcitabine in Locally Advanced Cervical Cancer Patients with Comorbidities
por: Brau-Figueroa, Hasan, et al.
Publicado: (2022)

Efficacy and safety of nimotuzumab combined with chemoradiotherapy in the treatment of locally advanced cervical cancer
por: Zhang, Lei, et al.
Publicado: (2022)

Concurrent chemoradiotherapy followed by adjuvant chemotherapy versus concurrent chemoradiotherapy alone in locally advanced cervical cancer: A systematic review and meta-analysis
por: Liu, Haonan, et al.
Publicado: (2022)

Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced‐stage ovarian cancer
por: Huang, Chueh‐Yi, et al.
Publicado: (2020)

Distant Metastasis Risk Definition by Tumor Biomarkers Integrated Nomogram Approach for Locally Advanced Nasopharyngeal Carcinoma
por: Fan, Xinjuan, et al.
Publicado: (2019)

Cost-effectiveness of para-aortic lymphadenectomy before chemoradiotherapy in locally advanced cervical cancer
por: Lee, Jung-Yun, et al.
Publicado: (2015)

Epithelial–mesenchymal transition, proliferation, and angiogenesis in locally advanced cervical cancer treated with chemoradiotherapy
por: Rojas‐Puentes, Leonardo, et al.
Publicado: (2016)

Analysis of Treatment Outcomes and Prognosis After Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
por: Peng, Qing-he, et al.
Publicado: (2022)

Outcomes and prognostic factors in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy
por: Liu, Jing, et al.
Publicado: (2022)

Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial
por: Rodrigues, Manuel, et al.
Publicado: (2023)

Neoadjuvant Chemoradiotherapy and Larynx-Preserving Surgery for Cervical Esophageal Cancer
por: Dai, Kun-Yao, et al.
Publicado: (2020)

Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumour heterogeneity
por: Fjeldbo, Christina S., et al.
Publicado: (2020)

Use of Baseline (18)F-FDG PET/CT to Identify Initial Sub-Volumes Associated With Local Failure After Concomitant Chemoradiotherapy in Locally Advanced Cervical Cancer
por: Lucia, François, et al.
Publicado: (2020)

Individualized pelvic lymphadenectomy should follow neoadjuvant concurrent chemoradiotherapy for locally advanced cervical cancer
por: Wei, Li-Chun, et al.
Publicado: (2018)

Clinical significance of lymph node size in locally advanced cervical cancer treated with concurrent chemoradiotherapy
por: Oh, Jinju, et al.
Publicado: (2019)

Role of (18)FDG PET/CT metabolic parameters in predicting hematological toxicity during chemoradiotherapy for locally advanced cervical cancer
por: Meng, Tianyu, et al.
Publicado: (2022)

Predicting distant metastasis and chemotherapy benefit in locally advanced rectal cancer
por: Liu, Zhenyu, et al.
Publicado: (2020)

Explainable machine learning model for predicting skeletal muscle loss during surgery and adjuvant chemotherapy in ovarian cancer
por: Hsu, Wen‐Han, et al.
Publicado: (2023)

Impact of chemoradiotherapy on the survival of unresectable locally advanced pancreatic cancer: a retrospective cohort analysis
por: Wang, Zi-Meng, et al.
Publicado: (2023)

Leukocytosis, prognosis biomarker in locally advanced head and neck cancer patients after chemoradiotherapy
por: Schernberg, Antoine, et al.
Publicado: (2018)

Predictive Biomarkers of Pathological Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Soft Tissue Sarcomas
por: Szumera-Ciećkiewicz, Anna, et al.
Publicado: (2023)

Impact of Weight Loss on Patients with Locally Advanced Esophageal and Esophagogastric Junction Cancers Treated with Chemoradiotherapy
por: Wiwitkeyoonwong, Jirapath, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0vgohmqb0htnk0ld2qg64q468o